Pharma Focus Asia

Catalent Invests US$9million in a New Clinical Supply Facility in San Diego


Catalent has invested US$9million in a new clinical supply facility in San Diego.


The new 24,257 square-feet facility is expected to provide clinical supply services to clients in the early stages of clinical development.

The site operations will include product packaging, labeling, storage, and distribution, as well as drug returns and destruction, while the facility will also have stability chambers.

The facility will be located less than a mile from the company's early-phase oral drug product development site and is expected to start its operations in the summer of 2020.

The new facility will join two existing Catalent global centers of excellence in oral dose early-phase development in Somerset, New Jersey and Nottingham, UK.  


LocationSan Diego
TypeNew Construction
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference